NextNRG Finalizes Reverse Split, $30M Toxic Financing, and Massive CEO Pay Package
NXXT is trading near its 52-week low of $0.203 (15% above the low) on light trading volume (0.2× avg).
Summary
NextNRG's definitive 14C makes effective a reverse stock split, a $30M toxic preferred financing with a $0.135 floor price, and a CEO pay package that could grant Michael Farkas up to 10% of the company at market cap milestones. The initial $9.2M financing tranche already closed.
Updates
· SEC S-1 — The S-1 registers 112,946,708 shares for resale, assuming a 105% conversion premium, 12.5% annual dividends compounded monthly for three years, and the $0.135 floor price. The initial closing yielded $7.2 million net after cancelling the $2 million note.
Key Events · Corporate Governance and Compliance · NXXT
-
Reverse Stock Split Approved
Board authorized a 1-for-5 to 1-for-12 reverse split to regain Nasdaq's $1.00 minimum bid price. Company received delisting notice on March 16, 2026, with compliance deadline September 14, 2026.
-
Series C Financing Initial Closing
On August 13, 2026, NextNRG issued 1,000,000 Series C Preferred Shares for $9.2 million. The shares convert at $0.75 initially, with a floor price of $0.135, potentially creating up to 74,074,074 common shares (30.6% dilution).
-
CEO Compensation Package
Michael Farkas' employment agreement includes $720,000 base salary, $2,000,000 annual equity salary, and market cap bonuses of 10% of outstanding shares at $500M, $1B, $2B, $4B, and $8B thresholds. Signing bonus is $8,160,000 in restricted stock.
-
Equity Plan Expansion
2023 Equity Incentive Plan shares increased by 32,000,000 to 54,250,000, a 144% increase, to accommodate the CEO's equity awards and other grants.
Analysis · NXXT · Trade & Services
This definitive information statement makes effective a package of highly dilutive and governance-heavy actions: a reverse stock split to avoid Nasdaq delisting, a $30 million Series C preferred financing with a $0.135 floor price that could dilute existing holders by over 30%, and an employment agreement granting CEO Michael Farkas up to 10% of the company's shares at various market cap milestones. The initial $9.2 million tranche of the toxic financing already closed on August 13, 2026, and the company remains under going-concern warning with critically low cash. The CEO's compensation package is unusually aggressive for a company of this size and financial condition, and the reverse split is a last-ditch effort to maintain Nasdaq listing.
How filings like this one have moved
In the 30 days to Oct 21, 2026, 37.2% of the 999 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.80%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NXXT was trading at $0.23 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $39.3M. The 52-week trading range was $0.20 to $2.88. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.